Breaking News Instant updates and real-time market news.

XOM

Exxon Mobil

$80.86

1.35 (1.70%)

, CVX

Chevron

$124.22

1.53 (1.25%)

20:25
04/26/18
04/26
20:25
04/26/18
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's market open, with earnings consensus, include Exxon (XOM), consensus $1.13... Chevron (CVX), consensus $1.48... Sanofi (SNY), consensus 56c... Charter Communications (CHTR), consensus 55c... Colgate-Palmolive (CL), consensus 73c... Philips66 (PSX), consensus 89c... Simon Property Group (SPG), consensus $1.52... Dominion Energy (D), consensus $1.06... LyondellBasell Industries (LYB), consensus $2.75... Moody's (MCO), consensus $1.80... Weyerhaeuser (WY), consensus 33c... Rockwell Collins (COL), consensus $1.77... Honda Motor Company (HMC).

XOM

Exxon Mobil

$80.86

1.35 (1.70%)

CVX

Chevron

$124.22

1.53 (1.25%)

SNY

Sanofi

$40.37

0.265 (0.66%)

CHTR

Charter

$297.00

-3.37 (-1.12%)

CL

Colgate-Palmolive

$66.60

0.18 (0.27%)

PSX

Phillips 66

$113.00

3.18 (2.90%)

SPG

Simon Property

$150.18

3.4 (2.32%)

D

Dominion

$65.04

0.22 (0.34%)

LYB

LyondellBasell

$106.51

1.11 (1.05%)

MCO

Moody's

$164.56

1.955 (1.20%)

WY

Weyerhaeuser

$36.64

0.46 (1.27%)

COL

Rockwell Collins

$133.00

-0.26 (-0.20%)

HMC

Honda

$34.78

0.18 (0.52%)

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 07

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 09

    May

  • 15

    May

  • 20

    May

  • 20

    May

  • 20

    May

  • 22

    May

  • 30

    May

  • 25

    Jun

  • 20

    Oct

  • 28

    Jan

XOM Exxon Mobil
$80.86

1.35 (1.70%)

04/23/18
04/23/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Michael Kors (KORS) upgraded to Buy from Hold at Deutsche Bank with analyst Paul Trussell saying the company is in the "middle innings" of a turnaround and is nearing an inflection point. 2. Verizon (VZ) upgraded to Overweight from Equal Weight at Barclays with analyst Amir Rozwadowski saying the company is better positioned than the current valuation implies. 3. Under Armour (UA, UAA) upgraded to Hold from Sell at Deutsche Bank with analyst Paul Trussell saying estimates for the first quarter and fiscal 2018 earnings are attainable, reflecting improved sell-through of new products and a commitment to cost reduction. 4. Hanesbrands (HBI) upgraded to Buy from Hold at Stifel with analyst Jim Duffy noting that the Champion brand is experiencing positive momentum in the lifestyle apparel space while its acquisitions in recent years have diversified the revenue mix and improved the overall portfolio's characteristics. 5. Exxon Mobil (XOM) upgraded to Market Perform from Underperform at Raymond James with analyst Pavel Molchanov saying Exxon's dividend yield has widened at a near-record level of 3.9% and there is a realistic chance the company will reinstate a share buyback in the near future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/18
RAJA
04/23/18
UPGRADE
RAJA
Market Perform
Exxon Mobil upgraded to Market Perform on valuation at Raymond James
As previously reported, Raymond James upgraded Exxon Mobil to Market Perform from Underperform. Analyst Pavel Molchanov said Exxon's dividend yield has widened ot a near-record level of 3.9% and there is a realistic chance the company will reinstate a share buyback in the near future.
04/23/18
RAJA
04/23/18
UPGRADE
RAJA
Market Perform
Exxon Mobil upgraded to Market Perform from Underperform at Raymond James
04/10/18
BOFA
04/10/18
NO CHANGE
Target $100
BOFA
Buy
Exxon Mobil added to US 1 List at BofA/Merrill
BofA/Merrill analyst Doug Leggate added ExxonMobile to the US 1 List telling investors shares are discounting the lowest long-term oil price in the sector at $48/bbl. Leggate believes Exxon's upstream portfolio leverage is being overlooked following the collapse in oil prices and shares are poised for a recovery following year-to-date lagging performance. Leggate rates Exxon Mobile a Buy with a $100 price target.
CVX Chevron
$124.22

1.53 (1.25%)

03/20/18
JPMS
03/20/18
NO CHANGE
Target $135
JPMS
Overweight
Chevron pullback brings favorable entry point, says JPMorgan
JPMorgan analyst Phil Gresh says the pullback in Chevron shares to below $115 brings a favorable entry point. The analyst sees a "balanced long-term story" around production growth, free cash flow generation, and return of capital through at least 2022 with "fairly low execution risk." The analyst believes the "penalty box" following the "messy" Q4 will be temporary. He raised his price target for Chevron to $135 from $130 and keeps an Overweight rating on the shares.
02/28/18
02/28/18
UPGRADE
Target $138

Buy
Chevron upgraded to Buy on valuation at BofA/Merrill
As previously reported, BofA/Merrill upgraded Chevron to Buy from Neutral and maintained a $138 price target. Analyst Doug Leggate views valuation as attractive following the recent pullback in shares combined with his views of an improving commodity backdrop.
04/12/18
WELS
04/12/18
NO CHANGE
Target $153
WELS
Outperform
Chevron price target raised to $153 from $138 at Wells Fargo
Wells Fargo raised its price target for Chevron to $153 from $138 on valuation as it believes 2018 is a year that will reward the more aggressively positioned energy investor. The firm reiterated an Outperform rating on the shares.
04/19/18
JEFF
04/19/18
DOWNGRADE
Target $68
JEFF
Hold
ConocoPhillips downgraded to Hold from Buy at Jefferies
Jefferies analyst Jason Gammel downgraded ConocoPhillips (COP) to Hold with a $68 price target citing valuation following the recent rally in the shares. The analyst prefers shares of Chevron (CVX) for U.S. oil exposure.
SNY Sanofi
$40.37

0.265 (0.66%)

02/19/18
JEFF
02/19/18
NO CHANGE
Target $145
JEFF
Buy
AnaptysBio price target raised to $145 from $101 at Jefferies
Jefferies analyst Biren Amin raised his price target for AnaptysBio (ANAB) to $145 after the company presented final data from its Phase IIa trial of ANB020 in 12 mod-to-severe adult atopic dermatitis patients. The shares closed Friday up $6.59, of 5.5%, to $126.45. Sustained efficacy on a single dose of '020 was seen up to day 78 at EASI-50 in 75% of patients, comparable to Phase II data from Sanofi (SNY) and Regeneron (REGN) competitor Dupixent, Amin tells investors in a research note. ANB020 beats if you account for single dose versus Q2 weeks of Dupi, the analyst contends. He keeps a Buy rating on AnaptysBio.
02/26/18
LEER
02/26/18
NO CHANGE
LEER
Leerink remains positive on Regeneron/Sanofi Dupixent
Leerink analyst Geoffrey Porges says sentiment about the revenue potential of Regeneron (REGN)/Sanofi's (SNY) Dupixent has been declining over the past year, despite an impressive launch, and a steady flow of data for new indications and populations. The analyst remains positive about the product, forecasting 2020 revenue of $4B and growing to $6.5B by 2022 and $7.8B by 2025 from multiple indications.
03/12/18
RILY
03/12/18
NO CHANGE
Target $200
RILY
Buy
Alnylam bear argument undercut by Regeneron data, says B. Riley FBR
B. Riley FBR analyst Madhu Kumar believes this weekend's Odyssey Outcomes data from Regeneron (REGN) and Sanofi (SNY) undercuts the bear argument on Alnylam Pharmaceuticals (ALNY) that PCSK9 drugs do not demonstrate clinically meaningful mortality benefit. Further, the analyst believes Sanofi and Regeneron's lower Praluent pricing in high-risk patients will likely expand uptake of PCSK9 drugs in the cholesterol market. Kumar keeps a Buy rating on Alnylam with a $200 price target.
03/12/18
PIPR
03/12/18
NO CHANGE
Target $182
PIPR
Overweight
Piper says Sanofi decision not to op-in on lumasiran positve for Alnylam
Piper Jaffray analyst Edward Tenthoff said he views Sanofi's (SNY) decision not to opt-in for global rights on lumasiran for the treatment of Primary Hyperoxaluria Type 1, or PH1, as a positive for Alnylam (ALNY), as he believes lumasiran could represent a fourth RNAi therapy with potential approval by 2020. Tenthoff, who said he is confident in FDA approval of patisiran by the August 11 PDUFA date and expects givosiran approval in 2019, keeps an Overweight rating and $182 target on Alnylam shares.
CHTR Charter
$297.00

-3.37 (-1.12%)

03/26/18
COWN
03/26/18
INITIATION
COWN
Outperform
Charter initiated with an Outperform at Cowen
02/07/18
RBCM
02/07/18
NO CHANGE
Target $420
RBCM
Outperform
Charter price target raised to $420 from $400 at RBC Capital
RBC Capital analyst Jonathan Atkin raised his price target on Charter to $420 and kept his Outperform rating after "solid" Q4 earnings "highlighted by improving video subscriber trends in the legacy Time Warner Cable footprint". Atkin expects Q4 to mark the trough in EBITDA growth as the Spectrum pricing and packaging penetration increases to about 70% by 2018-end, generating "reduced transaction volumes and a longer-tenured subscriber base".
02/05/18
RHCO
02/05/18
NO CHANGE
Target $440
RHCO
Buy
Charter price target raised to $440 from $380 at SunTrust
SunTrust analyst Greg Miller raised his price target on Charter to $440, saying the company's Q4 results support his view for video subscriber growth this year. The analyst notes signs of churn stabilizing in the Time Warner Cable markets and net adds in Bright House, removing some of the overhang on the stock. Miller keeps his Buy rating on Charter, adding that its pricing and packaging strategies are helping the company turn the corner on net adds.
02/05/18
02/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Lowe's (LOW) upgraded to Buy from Hold at Jefferies with analyst Daniel Binder saying his "deep-dive" analysis suggests the company can double EBIT and triple earnings within five years. 2. Charter (CHTR) upgraded to Outperform from Market Perform at Wells Fargo with analyst Marci Ryvicker saying she has "renewed confidence" in a successful turnaround despite a tough competitive environment. 3. Sprint (S) upgraded to Sector Weight from Underweight at KeyBanc with analyst Brandon Nispel saying the third quarter results were better than feared. 4. PayPal (PYPL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Timothy Willi saying the strength of PayPal's competitive position and "substantial tailwinds" driving e-commerce growth will outweigh any negative earnings headwind that may emerge from the company's transitioning relationship with eBay (EBAY). 5. Norwegian Cruise Line (NCLH) upgraded to Overweight from Neutral at JPMorgan analyst Joseph Greff saying he believes demand and pricing trends in the Cruise Line industry continue to show momentum, and his channel checks indicate Norwegian has had the most pricing momentum over the past few months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CL Colgate-Palmolive
$66.60

0.18 (0.27%)

04/20/18
DBAB
04/20/18
NO CHANGE
Target $80
DBAB
Hold
Deutsche Bank downgrades Procter & Gamble, Church & Dwight to Hold
Deutsche Bank analyst Steve Powers downgraded both Procter & Gamble (PG) and Church & Dwight (CHD) to Hold from Buy saying Household & Personal Care is "in a tough spot." The analyst expects incremental pricing pressure to build over the course of 2018 in many categories. Perhaps as a result of tax reform, combined with pre-existing competition, retailers and manufacturers seem willing to reinvest aggressively in order to preserve share, Powers tells investors in a research note. He views this as a "troublesome set-up" for Household & Personal Care names. Along with the two downgrades, the analyst lowered his price targets for Kimberly-Clark (KMB), Edgewell Personal (EPC), Colgate-Palmolive (CL) and Clorox (CLX).
01/30/18
EXAN
01/30/18
DOWNGRADE
EXAN
Underperform
Colgate-Palmolive downgraded to Underperform at Exane BNP Paribas
01/29/18
MSCO
01/29/18
NO CHANGE
Target $82
MSCO
Overweight
Colgate-Palmolive guidance 'clearly' seems conservative, says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian said Colgate-Palmolive's 2018 EPS guidance clearly looks conservative and he sees positive revisions as likely, assuming consensus moves closer to the company's view. Despite Colgate's weaker than expected organic sales rebound in Q4, he still views the stock as a relative outperformer in 2018 as he expects organic sales growth towards the high-end of consumer packaged goods peers and he is forecasting ad spending will be up 12.5% year-over-year, Mohsenian tells investors. He trimmed his price target on Colgate shares to $82 from $83 and keeps an Overweight rating.
12/27/17
JEFF
12/27/17
NO CHANGE
JEFF
Nielsen shows improved two-week sales trends, says Jefferies
Jefferies analyst Kevin Grundy says two-week sales growth in U.S. Nielsen channels improved sequentially for key home and personal care companies Colgate-Palmolive (CL), Church & Dwight (CHD) and Clorox (CLX), as well as beverage companies Monster Beverage (MNST), Coca-Cola (KO) and Dr Pepper Snapple (DPS). While overall growth remains tepid, sequential improvement in December for consumer spending, including staples, has been more upbeat, Grundy tells investors in a research note titled "Party Like It's 1999? Not Quite, But US Nielsen HPC/Bevs 2-Week Data Improves." The analyst favors shares of Church & Dwight, Procter & Gamble (PG), Dr Pepper and Monster.
PSX Phillips 66
$113.00

3.18 (2.90%)

04/13/18
04/13/18
UPGRADE
Target $60

Equal Weight
HollyFrontier upgraded to Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley analyst Benny Wong upgraded HollyFrontier (HFC) to Equal Weight from Underweight as his updated commodity assumptions, particularly for Midland differential, lifted his 2018 EBITDA estimate 34% above consensus. He raised his price target on HollyFrontier shares to $60 from $48. However, after speaking to Refining & Marketing companies, he is lowering his Q1 EPS estimates for the space by 30%. Wong sees HollyFrontier and Phillips 66 (PSX) as facing the least negative earnings revision risk, while seeing Delek US (DK), PBF Energy (PBF) and Marathon Petroleum (MPC) facing the highest revision risk.
11/14/17
11/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. General Electric (GE) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray saying that he now expects the turnaround at the company to be more protracted than previously anticipated, noting the roadmap laid out by new CEO John Flannery fell short of expectations regarding the scope of the business model/portfolio changes. 2. Phillips 66 (PSX) downgraded to Underweight from Equal Weight at Barclays analyst Paul Cheng saying the company's diversified business model will likely drive underperformance in a strong margin uptrend environment for U.S. refiners. 3. Hilton (HLT) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Stephen Grambling citing the recent outperformance of the stock for the rating change, but he expects consistent double-digit earnings growth on low single-digit RevPAR. 4. PulteGroup (PHM) downgraded to Neutral from Buy at Buckingham with the firm citing recent share strength and raised its price target to $33 from $31. 5. Albemarle (ALB) downgraded to Hold from Buy at Deutsche Bank with analyst David Begleiter downgraded Albemarle (ALB) to Hold from Buy while raising his price target for the shares to $150 from $130. Following a field trip to China, Begleiter believes new lithium processing capacity is coming, which should begin to pressure prices by 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/18
FBCO
01/03/18
INITIATION
Target $108
FBCO
Neutral
Phillips 66 initiated with a Neutral at Credit Suisse
Credit Suisse analyst Kristina Kazarian started Phillips 66 with a Neutral rating and $108 price target saying she like its diversification and balanced focus on growth/shareholder returns, but sees limited near-term upside for the stock as she believes short-term headwinds will overshadow long-term secular tailwinds-notably the cash flow inflection as these projects all reach full utilization.
03/14/18
COWN
03/14/18
NO CHANGE
COWN
Tailwinds outstrip headwinds in refining outlook, says Cowen
Cowen analyst Sam Margolin said he has a constructive refining outlook despite the current headwinds that include increased China capacity and a Brent/WTI compression. The analyst said the second half of the year should see those headwinds pass and said outside of global demand growth, MARPOL shipping industry regulations are requiring low sulfur marine fuel worldwide, and U.S. Tier-3 gasoline requirements could result in lower octane supply as a consequence of the de-sulferization processes. Margolin favors Valero (VLO), Phillips 66 (PSX), Delek (DK), Marathon (MPC), and Andeavor (ANDV) in the refining space.
SPG Simon Property
$150.18

3.4 (2.32%)

12/04/17
DBAB
12/04/17
NO CHANGE
Target $187
DBAB
Hold
Simon, Starbucks ruling could create 'slippery slope,' says Deutsche Bank
Deutsche Bank analyst Vin Chao notes that according to a news report, an Indiana court has temporarily prevented Starbucks (SBUX) from closing 77 of its Teavana stores. Simon Property Group (SPG) likely felt it necessary to make a case against a high profile tenant to stem others from taking a similar path, Chao tells investors in a research note. The analyst believes the ruling "could create a potentially slippery slope" for companies interested in shedding underperforming properties. He finds it likely that other mall landlords will file similar suits against Teavana given Simon's success. Further, Simon's lawsuit highlights the currently difficult leasing environment and "to some degree calls into question the strength of demand for high quality mall space," Chao adds. He has a Hold rating on Simon Property with a $187 price target.
03/27/18
03/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Newell Brands (NWL) downgraded to Hold from Buy at SunTrust with analyst William Chappell saying the stock is in "no-man's land" for a few quarters after its decision to increase its asset sale to $10B from $6B without disclosing which assets are sold following its recent agreement with activist shareholder Starboard Value. 2. Macerich (MAC) and Simon Property (SPG) were downgraded to Neutral from Overweight at JPMorgan. 3. Kimco Realty (KIM) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Richard Hill saying he is cautious on REITs in general, but higher quality strips are better positioned to mitigate decelerating growth risks. 4. Range Resources (RRC) downgraded to Market Perform from Outperform at Bernstein with analyst Bob Brackett saying he believes gas levered names, particularly those with significant debt loads, are likely to struggle as gas prices compress cash margins. 5. Dominion Midstream (DM) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/27/18
JPMS
03/27/18
DOWNGRADE
Target $175
JPMS
Neutral
Simon Property downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Michael Mueller downgraded Simon Property Group (SPG) to Neutral and lowered his price target for the shares to $175 from $188. The analyst is shuffling his ratings in the REIT space following GGP's (GGP) takeout by Brookfield Property Partners (BPY). He believes the price paid by Brookfield makes his "bullish mall thesis harder to push."
09/11/17
BMOC
09/11/17
INITIATION
BMOC
Outperform
Simon Property initiated with an Outperform at BMO Capital
BMO Capital analyst Jeremy Metz initiated Simon Property with an Outperform and a $78 price target.
D Dominion
$65.04

0.22 (0.34%)

03/28/18
STFL
03/28/18
NO CHANGE
STFL
Buy
Dominion roll-up of Dominion Midstream looks increasingly likely, says Stifel
Stifel analyst Timothy Howard notes that Dominion Midstream (DM) has said it expects that any impact from FERC-regulated interstate pipelines will be applied prospectively and only after a multi-year rate proceeding process. Sponsor Dominion Energy (D) has remarked that MLP market conditions are having a materially negative impact on potential equity issuance for Dominion Midstream, leaving Dominion to review its options. He believes Dominion ultimately acquiring Dominion Midstream is the most likely resolution, Howard tells investors. The analyst has a Buy rating on Dominion Midstream.
03/29/18
HDLY
03/29/18
NO CHANGE
Target $76
HDLY
Buy
Dominion price target lowered to $76 from $86 at Hilliard Lyons
Hilliard Lyons analyst David Burks lowered his price target for Dominion Energy (D) to $76 citing the "unexpected negative ruling" by the Federal Energy Regulatory Commission on March 15 that master limited partnership interstate natural gas and oil pipelines can't recover an income tax allowance in cost-of-service rates. This negatively impacts Dominion through its ownership stake in Dominion Energy Midstream Partners (DM), Hilliard Lyons tells investors in a research note. The analyst keeps a Buy rating on Dominion Energy.
04/05/18
ARGS
04/05/18
NO CHANGE
Target $87
ARGS
Buy
Dominion offers value to long term investors, says Argus
Argus analyst Jacob Kilstein writes that Dominion Resources, as one of the biggest names in storage, production and transporting of energy, offers value to long term investors thanks to its "strong cash flow, solid financial position, and annual dividend increases". While the analyst lowers his price target on Dominion to $87 from $90 to reflect the company's planned new share issuance and disappointing guidance, he is positive on its increasing investments in midstream assets and in electric utility/transmission, keeping his Buy rating on the stock.
04/13/18
WELS
04/13/18
NO CHANGE
Target $68
WELS
Market Perform
Dominion price target lowered to $68 from $77 at Wells Fargo
Wells Fargo analyst Sarah Akers lowered her price target for Dominion Energy to $68 and keeps a Market Perform rating on the name. The analyst updated her earnings outlook and investment thesis to reflect the absence of previously planned drop-downs and the recently announced forward equity offering.
LYB LyondellBasell
$106.51

1.11 (1.05%)

02/16/18
LBOW
02/16/18
DOWNGRADE
LBOW
Neutral
A. Schulman downgraded to Neutral from Buy at Longbow
As reported earlier, Longbow analyst Dmitry Silversteyn downgraded A. Schulman (SHLM) to Neutral from Buy after the company's stock price rose above LyondellBasell's (LYB) offer price. The analyst believes that investors' expectations of a higher bid may go unfulfilled and the upside in the stock price is limited, as any competing bid would have to top LyondellBasell's by at least $2 to compensate for the associated $50M break-up fee.
02/16/18
MSCO
02/16/18
NO CHANGE
Target $130
MSCO
Overweight
Morgan Stanley says A. Schulman deal doesn't alter Lyondell's bigger M&A plans
Morgan Stanley analyst Vincent Andrews believes LyondellBasell's (LYB) acquisition of A. Schulman (SHLM) was well priced, increases the value and optionality of Lyondell's existing compounding business, likely has cost synergies upside and has the potential for revenue synergies. With all of that said, he also does not believe the deal has read through to LyondellBasell's larger scale M&A plans. Andrews reiterates his Overweight rating and $130 price target on LyondellBasell shares.
02/08/18
SBSH
02/08/18
NO CHANGE
SBSH
Buy
DowDuPont added to Focus List after pullback at Citi
Citi analyst P.J. Juvekar added DowDuPont (DWDP) to his firm's Focus List citing the recent pullback in the shares. His top three picks in Chemicals are now DowDuPont, LyondellBasell (LYB) and Huntsman (HUN). Juvekar keeps a Buy rating on shares of DowDuPont.
03/27/18
BMOC
03/27/18
INITIATION
Target $111
BMOC
Outperform
LyondellBasell initiated with an Outperform at BMO Capital
BMO Capital analyst John McNulty started LyondellBasell with an Outperform rating and $111 price target.
MCO Moody's
$164.56

1.955 (1.20%)

04/25/18
NOMU
04/25/18
NO CHANGE
Target $190
NOMU
Buy
Moody's price target raised to $190 from $180 at Nomura Instinet
Nomura Instinet analyst Dan Dolev raised his price target for Moody's to $190 saying his revenue empirical study of global debt issuance versus the company's ratings organic growth points to potential 3%-4% upside to consensus estimates. The analyst reiterates a Buy rating on the shares.
02/14/18
ARGS
02/14/18
NO CHANGE
Target $190
ARGS
Buy
Moody's price target raised to $190 from $165 at Argus
Argus analyst John Eade raised his price target on Moody's to $190 and kept his Buy rating after a Q4 earnings beat, with results benefiting from the recent acquisition of Bureau van Dijk. The analyst is positive on the company's position to benefit from the "secular trends of global GDP growth and debt market disintermediation", along with opportunities to develop new products, raise margins, and grow through targeted acquisitions. Eade believes the valuation on Moody's is attractive relative to peers, with expected FY18 PE of 20.6-times vs. group range of 18-29-times.
02/12/18
FBCO
02/12/18
NO CHANGE
Target $187
FBCO
Neutral
Moody's price target raised to $187 from $161 at Credit Suisse
Credit Suisse analyst Anjaneya Singh raised his price target for Moody's to $187 from $161 after a "strong" update as expected, with margins looking a bit conservative. The analyst reiterates a Neutral rating on the shares.
02/12/18
WELS
02/12/18
NO CHANGE
Target $160
WELS
Market Perform
Moody's price target raised to $160 from $148 at Wells Fargo
Wells Fargo analyst William Warmington raised his price target for Moody's to $160 from $148 after the company reported Q4 revenue and EPS ahead of expectations, with upside driven primarily by strong issuance across all 4 divisions. The analyst reiterates a Market Perform rating on the shares.
WY Weyerhaeuser
$36.64

0.46 (1.27%)

01/24/18
BOFA
01/24/18
UPGRADE
Target $40
BOFA
Buy
Weyerhaeuser upgraded to Buy on improving pricing at BofA/Merrill
As previously reported, BofA/Merrill upgraded Weyerhaeuser to Buy from Neutral and raised its price target to $40 from $39. Analyst George Straphos views valuation as a "good entry point" ahead of expectations for strong lumber prices and flat-lining timber prices in the South, supporting strong margins in the wood products business. Staphos' research indicates an improved outlook for OSB pricing in 1H 2018, removing a near-term headwind.
01/24/18
BOFA
01/24/18
UPGRADE
BOFA
Buy
Weyerhaeuser upgraded to Buy from Neutral at BofA/Merrill
12/14/17
RAJA
12/14/17
NO CHANGE
RAJA
Raymond James Analysts' Best Picks for 2018
Raymond James named its Analysts' Best Picks for 2018. They are: Alaska Air (ALK), Alibaba (BABA), Becton Dickinson (BDX), Broadcom (AVGO), Continental Resources (CLR), Dollar Tree (DLTR), Fastenal (FAST), First Horizon (FHN), Flir Systems (FLIR), ICU Medical (ICUI), Progressive (PGR),ProPetro Holding (PUMP), ServiceNow (NOW), SS&C (SSNC), SVB Financial (SIVB), UnitedHealth (UNH), and Weyerhaeuser (WY).
10/24/17
SPHN
10/24/17
INITIATION
Target $35
SPHN
Equal Weight
Weyerhaeuser initiated with an Equal Weight at Stephens
Stephens analyst Mark Connelly started Weyerhaeuser with an Equal Weight rating and $35 price target, noting that expectations are relatively high but he sees lumber prices falling in 2018.
COL Rockwell Collins
$133.00

-0.26 (-0.20%)

11/08/17
FBCO
11/08/17
DOWNGRADE
Target $140
FBCO
Neutral
Rockwell Collins downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Robert Spingarn downgraded Rockwell Collins (COL) to Neutral citing the pending acquisition by United Technologies (UTX). The analyst raised his price target for the shares to $140 from $133.
01/05/18
BARD
01/05/18
UPGRADE
Target $156
BARD
Outperform
United Technologies upgraded to Outperform from Neutral at Baird
Baird analyst Peter Arment upgraded United Technologies (UTX) to Outperform from Neutral utilizing pro forma earnings of the pending Rockwell Collins (COL) deal and reflecting higher accretion from tax reform. Arment raised his price target to $156 from $121 on United Technologies shares.
01/16/18
01/16/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Neutral at Macquarie with analyst Laurent Vasilescu citing weaker North America revenues, flat Connected Fitness revenues, international revenues of up 21% year-over-year, gross margin pressure, and higher SG&A assumptions. 2. Verizon (VZ) downgraded to Neutral from Buy at MoffettNathanson. 3. Lockheed Martin (LMT) and Rockwell Collins (COL) were downgraded to Market Perform from Outperform at Wells Fargo. 4. Spirit Airlines (SAVE) downgraded to Hold from Buy at Stifel with analyst Joseph DeNardi saying he believes Spirit will benefit this year from an improving demand and revenue environment, but that its higher revenue risk relative to potential competitive responses to its expected capacity growth is not fully reflected in the stock at current levels. 5. Finisar (FNSR) downgraded to Sell from Neutral at Goldman Sachs with analyst Doug Clark saying risks of oversupply and competition are heating up in the optical component landscape. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/18
WELS
01/16/18
DOWNGRADE
Target $143
WELS
Market Perform
Rockwell Collins downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Sam Pearlstein downgraded Rockwell Collins to Market Perform saying the stock is largely driven by the pending acquisition by United Technologies (UTX). The analyst has a $143 price target for the shares.
HMC Honda
$34.78

0.18 (0.52%)

03/27/18
UBSW
03/27/18
UPGRADE
UBSW
Buy
Honda upgraded to Buy from Neutral at UBS
02/20/18
FBCO
02/20/18
UPGRADE
FBCO
Outperform
Honda upgraded to Outperform from Neutral at Credit Suisse
03/13/18
MSCO
03/13/18
NO CHANGE
MSCO
Morgan Stanley compares automakers to Facebook, Apple in 'Auto 2.0' model
Morgan Stanley analyst Adam Jonas noted that auto companies' valuations have compressed to extremely low levels, but he believes that a move from a vehicle ownership model to a transportation subscriber model could expand the revenue opportunities for the potential "tollkeepers" for the monetization of content and data by "nearly an order of magnitude." Looking at U.S. technology leaders Facebook (FB) and Apple (AAPL), which are both valued on their installed base/subscriber models, can "offer valuable clues" regarding the opportunity for General Motors (GM) and other auto OEMs, said Jonas. Viewing the OEMs though the lens of a subscription model, which should be less cyclical and potentially less capital intensive over time than the current auto model, is relevant to analyzing auto stocks, according to Jonas, who adds that it is still too early to call a winner or loser in "Auto 2.0." Other publicly traded legacy automakers include Fiat Chrysler (FCAU), Ford (F), Honda (HMC), Nissan (NSANY), Toyota (TM), Volkswagen (VLKAY) and Daimler (DDAIF).
02/15/18
JPMS
02/15/18
UPGRADE
JPMS
Overweight
Honda upgraded to Overweight from Neutral at JPMorgan

TODAY'S FREE FLY STORIES

SMMF

Summit Financial Group

$24.87

0.51 (2.09%)

16:03
09/18/18
09/18
16:03
09/18/18
16:03
Hot Stocks
Summit Financial Group annouces 500K stock repurchase program »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:57
09/18/18
09/18
15:57
09/18/18
15:57
Hot Stocks
Breaking Hot Stocks news story  

CBX trading resumes

SFBC

Sound Financial Bancorp

$39.90

(0.00%)

15:52
09/18/18
09/18
15:52
09/18/18
15:52
Hot Stocks
Breaking Hot Stocks news story on Sound Financial Bancorp »

FJ Capital reports 5.28%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCK

Crown Holdings

$47.88

1.7 (3.68%)

15:50
09/18/18
09/18
15:50
09/18/18
15:50
Options
Notable call spread in Crown Holdings as a bullish position is adjusted »

Notable call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$14.02

0.3 (2.19%)

, SCCO

Southern Copper

$41.84

0.76 (1.85%)

15:44
09/18/18
09/18
15:44
09/18/18
15:44
Periodicals
Copper prices advance on less harsh tariffs, WSJ says »

Copper prices climbed on…

FCX

Freeport McMoRan

$14.02

0.3 (2.19%)

SCCO

Southern Copper

$41.84

0.76 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:35
09/18/18
09/18
15:35
09/18/18
15:35
Hot Stocks
Breaking Hot Stocks news story  »

CBX trading halted, news…

BIOL

Biolase

$2.06

-0.02 (-0.96%)

15:30
09/18/18
09/18
15:30
09/18/18
15:30
Conference/Events
Biolase to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

TRXC

TransEnterix

$6.04

0.24 (4.14%)

15:25
09/18/18
09/18
15:25
09/18/18
15:25
Options
TransEnterix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

MB

Mindbody

$41.15

1.1 (2.75%)

15:25
09/18/18
09/18
15:25
09/18/18
15:25
Conference/Events
Mindbody to host analyst day »

Analyst day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
09/18/18
09/18
15:17
09/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
09/18/18
09/18
15:16
09/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGS

B&G Foods

$30.40

-1.15 (-3.65%)

15:10
09/18/18
09/18
15:10
09/18/18
15:10
Options
Bearish option flow in B & G Foods as shares drop 3.8% »

Bearish option flow in B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 06

    Nov

15:10
09/18/18
09/18
15:10
09/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

YELP

Yelp

$50.19

3.905 (8.44%)

15:05
09/18/18
09/18
15:05
09/18/18
15:05
Options
Yelp call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$20.35

9.95 (95.67%)

14:58
09/18/18
09/18
14:58
09/18/18
14:58
Recommendations
Viking Therapeutics analyst commentary  »

Viking price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 01

    Oct

ACHV

Achieve Life Sciences

$2.55

-0.05 (-1.92%)

14:56
09/18/18
09/18
14:56
09/18/18
14:56
Conference/Events
Achieve Life Sciences to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$362.55

12.31 (3.51%)

, VIA

Viacom

$33.80

0.05 (0.15%)

14:52
09/18/18
09/18
14:52
09/18/18
14:52
Hot Stocks
Netflix working on live-action version of 'Avatar: The Last Airbender' »

Netflix (NFLX) confirmed…

NFLX

Netflix

$362.55

12.31 (3.51%)

VIA

Viacom

$33.80

0.05 (0.15%)

VIAB

Viacom

$30.26

0.2 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

BX

Blackstone

$37.63

0.53 (1.43%)

14:47
09/18/18
09/18
14:47
09/18/18
14:47
Conference/Events
Blackstone to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

ING

ING Group

$13.00

0.05 (0.39%)

14:46
09/18/18
09/18
14:46
09/18/18
14:46
Syndicate
Breaking Syndicate news story on ING Group »

ING Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNST

Constellation Pharmaceuticals

$7.01

-0.64 (-8.37%)

14:44
09/18/18
09/18
14:44
09/18/18
14:44
Conference/Events
Constellation Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

  • 21

    Sep

NTDOY

Nintendo

$0.00

(0.00%)

14:41
09/18/18
09/18
14:41
09/18/18
14:41
Hot Stocks
Nintendo offering Fortnite bundle for Switch »

Nintendo of America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$46.06

-0.26 (-0.56%)

14:40
09/18/18
09/18
14:40
09/18/18
14:40
Hot Stocks
Coca-Cola acquires Australian maker of MOJO Kombucha, terms undisclosed »

The Coca-Cola Company has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SPWR

SunPower

$7.43

0.85 (12.92%)

14:35
09/18/18
09/18
14:35
09/18/18
14:35
Hot Stocks
SunPower spikes higher after receiving solar tariff exclusion »

Shares of solar solutions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$93.60

-1.77 (-1.86%)

14:35
09/18/18
09/18
14:35
09/18/18
14:35
Options
AbbVie put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAIC

SAIC

$77.37

-0.58 (-0.74%)

14:30
09/18/18
09/18
14:30
09/18/18
14:30
Conference/Events
SAIC management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.